Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026)
Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 555.10 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.47 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 101.25 Mn |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - | 11.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.37 Mn |
| Dec 31, 2025 | 12.26 Mn |
| Sep 30, 2025 | 6.29 Mn |
| Jun 30, 2025 | 7.40 Mn |
| Mar 31, 2025 | 6.27 Mn |
| Dec 31, 2024 | 8.08 Mn |
| Sep 30, 2024 | 11.86 Mn |
| Jun 30, 2024 | 8.10 Mn |
| Mar 31, 2024 | 9.68 Mn |
| Dec 31, 2023 | 12.08 Mn |
| Sep 30, 2023 | 12.24 Mn |
| Jun 30, 2023 | 12.29 Mn |
| Mar 31, 2023 | 12.29 Mn |
| Dec 31, 2022 | 11.83 Mn |
| Sep 30, 2022 | 8.21 Mn |
| Jun 30, 2022 | 14.60 Mn |
| Mar 31, 2022 | 13.28 Mn |
| Dec 31, 2021 | 8.91 Mn |
| Sep 30, 2021 | 8.66 Mn |
| Jun 30, 2021 | 9.13 Mn |